|
Status |
Public on Jan 15, 2015 |
Title |
FL15_mRNA |
Sample type |
RNA |
|
|
Source name |
CD19+ B cells
|
Organism |
Homo sapiens |
Characteristics |
tissue: LN tumor: FL1-2 age: 50 Sex: female previously treated for nhl: no cell type: follicular lymphoma
|
Treatment protocol |
none
|
Growth protocol |
none
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was purified using Qiagen RNeasy Kits according to the manufacturer’s protocol.
|
Label |
biotin
|
Label protocol |
Purified RNA was amplified using Nugen Ovation Pico SL or Ovation Pico kits and labeled using Nugen Encore Biotin kit
|
|
|
Hybridization protocol |
Products were hybridized to Affymetrix Human Gene 1.0 ST arrays according to the manufacturer’s protocol
|
Scan protocol |
GS3000
|
Description |
Gene expression analysis was performed for FL using Affymetrix Human Gene 1.0 ST arrays
|
Data processing |
Gene expression levels were determined using the Affymetrix Expression Console software (v1.2.0.20) with exon-level RMA analysis and default settings
|
|
|
Submission date |
Sep 30, 2014 |
Last update date |
Jan 15, 2015 |
Contact name |
Jacqueline Payton |
E-mail(s) |
jpayton@wustl.edu
|
Organization name |
Washington University School of Medicine
|
Department |
Pathology and Immunology
|
Street address |
660 S. Euclid Ave
|
City |
St. Louis |
State/province |
MO |
ZIP/Postal code |
63110 |
Country |
USA |
|
|
Platform ID |
GPL10739 |
Series (2) |
GSE61912 |
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (array) |
GSE62246 |
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma |
|